Browsing by Author White, Harvey D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 18 of 18
Issue DateTitleAuthor(s)Citation
2014Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable AnginaKeech, Anthony (Tony); Mann, Kristy; Simes, Robert John; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Sullivan, David; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAssociation of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable Angina, Journal of the American College of Cardiology, vol.63, 4, 2014,pp 345-354
2013Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyBarnes, Elizabeth; Keech, Anthony (Tony); Marschner, Ian (Colin); Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; Zeller, Tanja; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreChanges in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study, Journal of the American Heart Association, vol.2, 5, 2013,pp 1-12
2010Coronary disease in indigenous populations: summary from the CSANZ indigenous Cardiovascular Health ConferenceBrieger, David; Jeremy, Richmond; Kritharides, Leonard; Brown, Alex; Riddell, Tania; Tonkin, Andrew; Walsh, Warren; White, Harvey D.; Zeitz, Chris; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteCoronary disease in indigenous populations: summary from the CSANZ indigenous Cardiovascular Health Conference, Heart, Lung & Circulation (Online), vol.19, 5-6,pp 299-305
2006Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.Eckermann, Simon; Glasziou, Paul; Kirby, Adrienne; Mulray, Sarah; Simes, Robert John; Denton, Mary; Friedlander, D; Hunt, David; LIPID, S u; Magnus, Paul; Sallaberger, Michele; Tonkin, Andrew; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study., American Heart Journal, vol.151,(6),2006,pp 1305-1312
2004Effects Of Pravastatin On Coronary Events In 2073 Patients With Low Levels Of Both Low-Density Lipoprotein Cholesterol And High-Density Lipoprotein Cholesterol: Results From The Lipid Study.Barter, Philip; Keech, Anthony (Tony); Marschner, Ian; Simes, Robert John; Colquhoun, David; Glasziou, Paul; Hunt, David; Tonkin, Andrew; White, Harvey D.; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects Of Pravastatin On Coronary Events In 2073 Patients With Low Levels Of Both Low-Density Lipoprotein Cholesterol And High-Density Lipoprotein Cholesterol: Results From The Lipid Study., European Heart Journal (2005), vol.25,(9),2004,pp 771-777
2006Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques.O'Connell, Rachel; Simes, Robert John; Aylward, Philip A.; de Pasquale, Carmen G.; Edmond, John J.; French, John K; HERO-2, I v; Stewart, Ralph A H; White, Harvey D.; Williams, Barbara F.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreFrequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques., The American Journal of Cardiology 2005, vol.97,(7),2006,pp 947-951
2010The Inaugural CSANZ Indigenous Cardiovascular Health Conference: Conference Findings and Ways ForwardBrieger, David; Jeremy, Richmond; Kritharides, Leonard; Brown, Alex; Riddell, Tania; Tonkin, Andrew; Walsh, Warren; White, Harvey D.; Zeitz, Chris; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteThe Inaugural CSANZ Indigenous Cardiovascular Health Conference: Conference Findings and Ways Forward, Heart, Lung and Circulation, vol.193, 5-6, 2010,pp 269-272
2003International variation in the use of evidence-based medicines for acute coronary syndromesSimes, Robert John; Armstrong, Paul W.; Califf, Robert M.; Chang, Wei-Ching; Granger, Christopher B.; Kramer, Judith M.; Lee, Kyu-Haeng; Newby, Laura Kristin; Piegas, Leopoldo S.; Topol, Eric J.; Van de Werf, Frans J.; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials CentreInternational variation in the use of evidence-based medicines for acute coronary syndromes, European Heart Journal, vol.24,(23),2003,pp 2133-2141
2005Letter regarding article by Armstrong et al, "Lessons learned from a clinical trial" - ResponseSimes, Robert John; Armstrong, Paul W.; Califf, Robert; Granger, Christopher B.; Lee, Kerry L; Newby, L Kristin; Van de Werf, Frans; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials CentreLetter regarding article by Armstrong et al, "Lessons learned from a clinical trial" - Response, Circulation (Baltimore), vol.111, 23,pp e393-e393
2002Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow upHague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; MacMahon, Stephen; Simes, Robert John; Alyward, P; Colquhoun, David; Glasziou, P; Hunt, D; Thompson, P; Tonkin, A; West, M; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; School of Public Health: NH&MRC Clinical Trials CentreLong-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow up, The Lancet, vol.359,(N/A),2002,pp 1379-1387
2005Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trialsSimes, Robert John; et, al; Granger, Christopher; Labinaz, Marino; Lincoff, A. Michael; Mathias, Jasmine; Moliterno, David J.; Pieper, Karen; Simoons, Maarten L.; Van de Werf, Frans; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials CentreOutcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials, European Heart Journal (2005), vol.26,(2),2005,pp 128-136
2013Plasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart DiseaseBarnes, Elizabeth; Fournier, Marion; Simes, Robert John; Blankenberg, Stefan; Colquhoun, David M.; Nestel, Paul; Sullivan, David Richmond; Tonkin, Andrew; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePlasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.33, 12, 2013,pp 2902-2908
2005Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial.Kirby, Adrienne; Mehalski, Kirsty; Pollicino, Christine; Simes, Robert John; Baghurst, Katrine; Colquhoun, David; Nestel, Paul; Tonkin, Andrew; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Molecular Bioscience; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreRelation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial., American Journal of Clinical Nutrition, vol.81,(6),2005,pp 1322-1329
2010Rheumatic heart disease in indigenous populationsJeremy, Richmond; Kritharides, Leonard; Brieger, David; Brown, Alex; Riddell, Tania; Tonkin, Andrew; Walsh, Warren; White, Harvey D.; Zeitz, Chris; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteRheumatic heart disease in indigenous populations, Heart, Lung and Circulation (Print), vol.19, 5-6,pp 273-281
2004Risk Factors For Intracranial Hemorrhage And Nonhemorrhagic Stroke After Fibrinolytic Therapy (From The Gusto-I Trial).Simes, Robert John; Califf, Robert M; Gore, Joel M.; Granger, Christopher; Kandzari, David E; Lee, Kerry L; Longstreth, William T; Mahaffey, Kenneth W; Simoons, Maarten L.; Stebbins, Amanda; Topol, Eric J; Weaver, W Douglas; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials CentreRisk Factors For Intracranial Hemorrhage And Nonhemorrhagic Stroke After Fibrinolytic Therapy (From The Gusto-I Trial)., The American Journal of Cardiology, vol.93,(4),2004,pp 458-461
2006Statin use and sex-specific stroke outcomes in patients with vascular disease.Simes, Robert John; Bushnell, Cheryl D.; Califf, Robert M.; et, al; Goldstein, Larry B.; Graffagnino, Carmelo A.; Griffin, Jeffrey; Harrington, Robert A.; Mahaffey, Kenneth W.; Newby, L. Kristin; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials CentreStatin use and sex-specific stroke outcomes in patients with vascular disease., Stroke 2005, vol.37,(6),2006,pp 1427-1431
2010Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.Marschner, Ian; O'Connell, Rachel; Simes, Robert John; Armstrong, Paul W.; Aylward, Philip E G; Califf, Robert M.; Diaz, Raphael; French, John K; Granger, Christopher B.; Van de Werf, Frans; Varshavsky, Sergei; White, Harvey D.; Wilcox, Robert G; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreUnexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial., American Heart Journal, vol.159, 6,pp 988-997
2008The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID studyKirby, Adrienne; Pollicino, Christine; Simes, Robert John; Sullivan, David; Bickel, Christoph; Blankenberg, Stefan; Lubos, Edith; Munzel, Thomas F; Nestel, P; Schnabel, Renate; Tiret, Laurence; Tonkin, Andrew M; West, Malcolm J; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; Molecular & Microbial BioscienThe value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study, European Heart Journal, vol.29,(8),2008,pp 923-931